RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Charlotte, NC · Raleigh, NC · +41 more sites
4 recruiting multiple sclerosis studies with a site in Charlotte, NC.
Sponsor: Novartis Pharmaceuticals
Charlotte, NC · Raleigh, NC · +41 more sites
Sponsor: Sanofi
Charlotte, NC · Raleigh, NC · +32 more sites
Sponsor: TG Therapeutics, Inc.
Charlotte, NC · New Bern, NC · Raleigh, NC · +106 more sites
Sponsor: TG Therapeutics, Inc.
Charlotte, NC · Raleigh, NC · +39 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.